Proteomic Approaches to Primary Open Angle Glaucoma Mechanisms and Biomarkers
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
July 01, 2015 - June 30, 2017
Grant ID
G2015039
Summary
Glaucoma is an age-related ocular disease and leading cause of blindness. While age and intraocular pressure (IOP) are major risk factors for the development of primary open angle glaucoma (POAG), eye doctors cannot yet predict who will develop POAG. The identification of additional risk factors is a high priority. The proposed research will identify glaucoma-altered proteins in the clear fluid at the front of the eye (i.e., aqueous humor) that will lead to improved understanding of disease mechanisms and the identification of biomarkers that will assist in caring for glaucoma patients.
Related Grants
National Glaucoma Research
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
National Glaucoma Research
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
National Glaucoma Research
Novel Visualization of Aqueous Outflow: Uncovering Glaucoma Mechanisms and Therapeutic Targets
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Tyson Kim, MD, PhD
Current Organization
University of California, San Francisco
Novel Visualization of Aqueous Outflow: Uncovering Glaucoma Mechanisms and Therapeutic Targets
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Tyson Kim, MD, PhD
Current Organization
University of California, San Francisco